Related Articles
Establishment and characterization of the gemcitabine‑resistant human pancreatic cancer cell line SW1990/gemcitabine
Emodin reverses resistance to gemcitabine in pancreatic cancer by suppressing stemness through regulation of the epithelial‑mesenchymal transition
Emodin reverses gemcitabine resistance in pancreatic cancer cells via the mitochondrial apoptosis pathway in vitro
Emodin potentiates the antitumor effects of gemcitabine in pancreatic cancer cells via inhibition of nuclear factor-κB
Expression and promoter methylation analysis of ATP-binding cassette genes in pancreatic cancer